U.S. markets open in 9 hours 9 minutes
  • S&P Futures

    3,275.25
    -27.00 (-0.82%)
     
  • Dow Futures

    26,377.00
    -180.00 (-0.68%)
     
  • Nasdaq Futures

    11,207.00
    -135.75 (-1.20%)
     
  • Russell 2000 Futures

    1,549.40
    -9.00 (-0.58%)
     
  • Crude Oil

    36.40
    +0.23 (+0.64%)
     
  • Gold

    1,876.90
    +8.90 (+0.48%)
     
  • Silver

    23.61
    +0.25 (+1.07%)
     
  • EUR/USD

    1.1692
    +0.0014 (+0.12%)
     
  • 10-Yr Bond

    0.8350
    +0.0540 (+6.91%)
     
  • Vix

    37.59
    -2.69 (-6.68%)
     
  • GBP/USD

    1.2933
    +0.0010 (+0.08%)
     
  • USD/JPY

    104.3880
    -0.2220 (-0.21%)
     
  • BTC-USD

    13,404.95
    -82.28 (-0.61%)
     
  • CMC Crypto 200

    262.85
    +20.17 (+8.31%)
     
  • FTSE 100

    5,581.75
    -1.05 (-0.02%)
     
  • Nikkei 225

    23,204.07
    -127.87 (-0.55%)
     

PharmAthene announces U.S. patent for recombinant bioscavenger

PharmAthene announced that the U.S. Patent and Trademark Office issued U.S. patent number 8,729,245 to PharmAthene, with claims that cover methods for the production of its recombinant butyrlcholinesterase bioscavenger in mammalian cells. PharmAthene is initially developing rBChE as a pre- and post-exposure therapy for military and civilian victims of nerve agent attacks.